Page last updated: 2024-09-04

conivaptan and ranitidine

conivaptan has been researched along with ranitidine in 3 studies

Compound Research Comparison

Studies
(conivaptan)
Trials
(conivaptan)
Recent Studies (post-2010)
(conivaptan)
Studies
(ranitidine)
Trials
(ranitidine)
Recent Studies (post-2010) (ranitidine)
188176485029
18817645,2981,788445

Protein Interaction Comparison

ProteinTaxonomyconivaptan (IC50)ranitidine (IC50)
Potassium-transporting ATPase alpha chain 1Homo sapiens (human)0.04
AcetylcholinesteraseHomo sapiens (human)1.475
Potassium-transporting ATPase subunit betaHomo sapiens (human)0.04
Multidrug and toxin extrusion protein 1Homo sapiens (human)8.3

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for conivaptan and ranitidine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

2 other study(ies) available for conivaptan and ranitidine

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010